Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,073
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Location: Houston TX, Pittsburgh PA, Fairfax VA, Calverton MD,
Sponsor: Nuvectis Pharma, Inc.
Sex: All
Age: 18+
Code: NCT07315113
Phase1, Recruiting
Dose-escalation Study of Oral CX-4945
for
Advanced Solid Tumors, Breast Cancer,
Location: Houston TX, Fort Collins CO, Loveland CO, Scottsdale AZ
Sponsor: Cylene Pharmaceuticals
Sex: All
Age: 18+
Code: NCT00891280
Phase1, Recruiting
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
for
Head and Neck Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07101432
Phase1, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: Houston TX, Austin TX, San Antonio TX, Dallas TX,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase2, Recruiting
A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.
for
Advanced Solid Tumors
Location: Houston TX, San Antonio TX, St Louis MO,
Sponsor: FoRx Therapeutics AG
Sex: All
Age: 18+
Code: NCT07356453
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body